Masimo, which develops non-invasive patient monitoring products which measure oxygen level of blood and pulse rate, filed for IPO Tuesday. The company had originally filed for IPO in 2000 but withdrew its filing citing market conditions. Piper Jaffray and Deutsche Bank are bookrunning the deal. Terms have not yet been announced.
